Özgür Mehtap, Tayfur Toptas, Mehmet S. Dal, Fatma Keklik Karadag, Unal Atas, Güner H. Özsan, Nilgün Sayınalp, Guray Saydam, Mehmet Ali Uçar, Hakkı Onur Kırkızlar, Ozan Salim, Atakan Tekinalp, Fahir Özkalemkaş, Funda Pepedi, Olga M. Akay, Emrah Kılıçaslan, Semra Paydas, Sinem Civriz Bozdağ, Mehmet Yılmaz, Volkan Karakus, Fatma Gecgel Arikan, Tahir Darçın, Elcin Erdogan, Erkin Cinar, Vildan Gürsoy, Salih S. Durusoy, Elif Birtaş Ateşoğlu, Anıl Tombak, Nurhilal Büyükkurt, Muhit Özcan, Fevzi Altuntaş, Işık Kaygusuz Atagündüz, Burhan Ferhanoglu
{"title":"预测老年晚期霍奇金淋巴瘤患者生存期的新评分系统","authors":"Özgür Mehtap, Tayfur Toptas, Mehmet S. Dal, Fatma Keklik Karadag, Unal Atas, Güner H. Özsan, Nilgün Sayınalp, Guray Saydam, Mehmet Ali Uçar, Hakkı Onur Kırkızlar, Ozan Salim, Atakan Tekinalp, Fahir Özkalemkaş, Funda Pepedi, Olga M. Akay, Emrah Kılıçaslan, Semra Paydas, Sinem Civriz Bozdağ, Mehmet Yılmaz, Volkan Karakus, Fatma Gecgel Arikan, Tahir Darçın, Elcin Erdogan, Erkin Cinar, Vildan Gürsoy, Salih S. Durusoy, Elif Birtaş Ateşoğlu, Anıl Tombak, Nurhilal Büyükkurt, Muhit Özcan, Fevzi Altuntaş, Işık Kaygusuz Atagündüz, Burhan Ferhanoglu","doi":"10.1080/10428194.2024.2395458","DOIUrl":null,"url":null,"abstract":"Predictive prognostic scoring (PS) systems are not primarily applicable to elderly patients with classical Hodgkin lymphoma (cHL). The objective of this study was to develop a PS system for these p...","PeriodicalId":18047,"journal":{"name":"Leukemia & Lymphoma","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients\",\"authors\":\"Özgür Mehtap, Tayfur Toptas, Mehmet S. Dal, Fatma Keklik Karadag, Unal Atas, Güner H. Özsan, Nilgün Sayınalp, Guray Saydam, Mehmet Ali Uçar, Hakkı Onur Kırkızlar, Ozan Salim, Atakan Tekinalp, Fahir Özkalemkaş, Funda Pepedi, Olga M. Akay, Emrah Kılıçaslan, Semra Paydas, Sinem Civriz Bozdağ, Mehmet Yılmaz, Volkan Karakus, Fatma Gecgel Arikan, Tahir Darçın, Elcin Erdogan, Erkin Cinar, Vildan Gürsoy, Salih S. Durusoy, Elif Birtaş Ateşoğlu, Anıl Tombak, Nurhilal Büyükkurt, Muhit Özcan, Fevzi Altuntaş, Işık Kaygusuz Atagündüz, Burhan Ferhanoglu\",\"doi\":\"10.1080/10428194.2024.2395458\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Predictive prognostic scoring (PS) systems are not primarily applicable to elderly patients with classical Hodgkin lymphoma (cHL). The objective of this study was to develop a PS system for these p...\",\"PeriodicalId\":18047,\"journal\":{\"name\":\"Leukemia & Lymphoma\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-09-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Leukemia & Lymphoma\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/10428194.2024.2395458\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leukemia & Lymphoma","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10428194.2024.2395458","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients
Predictive prognostic scoring (PS) systems are not primarily applicable to elderly patients with classical Hodgkin lymphoma (cHL). The objective of this study was to develop a PS system for these p...
期刊介绍：
Leukemia & Lymphoma in its fourth decade continues to provide an international forum for publication of high quality clinical, translational, and basic science research, and original observations relating to all aspects of hematological malignancies. The scope ranges from clinical and clinico-pathological investigations to fundamental research in disease biology, mechanisms of action of novel agents, development of combination chemotherapy, pharmacology and pharmacogenomics as well as ethics and epidemiology. Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
